ACRVVSAKAN• 28 Days (Normalized)
ACRV vs AKAN (Acrivon Therapeutics Inc. vs Akanda Corp.)
Showing Closing Date Range from Aug, 21 to Sep, 18, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ACRV Performance $1.85
-16.29%
Acrivon Therapeutics Inc.
Normalized Baseline0.00%
AKAN Performance $3.22
-16.58%
Akanda Corp.
Normalized Baseline0.00%
Alpha Spread Margin ACRV LEADS
+0.29%
ACRV outperforming by 0.29%
ACRVAKAN
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ACRV AKAN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | ACRV Price | ACRV Gain (%) | AKAN Price | AKAN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 18, 2026 | $1.85 | -16.29% | $3.22 | -16.58% | +0.29% |
| Sep 17, 2026 | $1.70 | -23.08% | $2.94 | -23.83% | +0.75% |
| Sep 16, 2026 | $1.70 | -23.08% | $2.72 | -29.53% | +6.45% |
| Sep 15, 2026 | $1.83 | -17.19% | $2.66 | -31.09% | +13.90% |
| Sep 14, 2026 | $1.96 | -11.31% | $2.79 | -27.72% | +16.41% |
| Sep 11, 2026 | $2.00 | -9.50% | $3.07 | -20.47% | +10.97% |
| Sep 10, 2026 | $2.04 | -7.69% | $3.00 | -22.28% | +14.59% |
| Sep 09, 2026 | $1.99 | -9.95% | $3.25 | -15.80% | +5.85% |
| Sep 08, 2026 | $2.10 | -4.98% | $3.28 | -15.03% | +10.05% |
| Sep 04, 2026 | $2.13 | -3.62% | $3.35 | -13.21% | +9.59% |
| Sep 03, 2026 | $2.06 | -6.79% | $3.67 | -4.92% | -1.87% |
| Sep 02, 2026 | $2.15 | -2.71% | $3.74 | -3.11% | +0.40% |
| Sep 01, 2026 | $2.07 | -6.33% | $3.70 | -4.15% | -2.18% |
| Aug 31, 2026 | $2.09 | -5.43% | $4.08 | +5.57% | -11.00% |
| Aug 28, 2026 | $2.06 | -6.79% | $3.89 | +0.78% | -7.57% |
Page 1 of 2